tradingkey.logo
tradingkey.logo
검색

Artivion Inc

AORT
관심 목록에 추가
22.770USD
-0.170-0.74%
종가 05/15, 16:00ET시세는 15분 지연됩니다
1.11B시가총액
88.74P/E TTM

Artivion Inc

22.770
-0.170-0.74%

자세한 내용은 Artivion Inc 회사

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Inc 정보

종목 코드 AORT
회사 이름Artivion Inc
상장일Feb 12, 1993
CEOMackin (James Patrick)
직원 수1600
유형Ordinary Share
회계 연도 종료Feb 12
주소1655 Roberts Boulevard N W
도시KENNESAW
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호30144
전화17704193355
웹사이트https://artivion.com/
종목 코드 AORT
상장일Feb 12, 1993
CEOMackin (James Patrick)

Artivion Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
--
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
--
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
--
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
68.65K
--
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
53.80K
--
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
39.13K
+34.61%
Mr. Matthew A. (Matt) Getz
Mr. Matthew A. (Matt) Getz
Vice President - Human Resources
Vice President - Human Resources
34.12K
-27.61%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
--
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
--
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
--

수익 분석

통화: USD마지막 업데이트: Mon, Apr 6
통화: USD마지막 업데이트: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Aortic stent grafts
159.37M
36.11%
On X
101.74M
23.05%
Preservation Services
95.50M
21.64%
Bio Glue
76.60M
17.36%
Surgical sealants
76.60M
17.36%
Other
8.11M
1.84%
지역별USD
이름
수익
비율
International
227.25M
51.49%
United States
214.07M
48.51%
사업별
지역별
사업별USD
이름
수익
비율
Aortic stent grafts
159.37M
36.11%
On X
101.74M
23.05%
Preservation Services
95.50M
21.64%
Bio Glue
76.60M
17.36%
Surgical sealants
76.60M
17.36%
Other
8.11M
1.84%

주식 보유 통계

마지막 업데이트: Sun, May 10
마지막 업데이트: Sun, May 10
주주
주주 유형
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
12.17%
Nomura Investment Management Business Trust
5.38%
Fidelity Management & Research Company LLC
4.98%
Vanguard Capital Management, LLC
4.02%
Morgan Stanley Smith Barney LLC
3.78%
기타
69.67%
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
12.17%
Nomura Investment Management Business Trust
5.38%
Fidelity Management & Research Company LLC
4.98%
Vanguard Capital Management, LLC
4.02%
Morgan Stanley Smith Barney LLC
3.78%
기타
69.67%
주주 유형
주주
비율
Investment Advisor
50.56%
Investment Advisor/Hedge Fund
32.13%
Individual Investor
4.67%
Hedge Fund
4.36%
Private Equity
3.55%
Research Firm
1.49%
Pension Fund
1.01%
Bank and Trust
0.42%
Venture Capital
0.03%
기타
1.76%

기관 주식 보유

마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
449
45.29M
93.40%
+501.67K
2025Q4
410
43.29M
91.25%
+30.07K
2025Q3
417
43.26M
91.49%
+621.40K
2025Q2
388
42.72M
90.85%
+749.95K
2025Q1
378
41.65M
93.88%
+1.56M
2024Q4
361
38.77M
90.20%
+1.92M
2024Q3
344
36.62M
88.99%
+563.89K
2024Q2
325
36.03M
88.04%
+491.62K
2024Q1
322
35.76M
90.55%
-2.03M
2023Q4
321
34.94M
89.27%
+12.56K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
5.91M
12.33%
+292.30K
+5.21%
Dec 31, 2025
Nomura Investment Management Business Trust
2.61M
5.46%
+129.63K
+5.22%
Dec 31, 2025
Fidelity Management & Research Company LLC
2.42M
5.05%
-420.69K
-14.81%
Dec 31, 2025
Morgan Stanley Smith Barney LLC
1.83M
3.83%
-32.21K
-1.73%
Dec 31, 2025
Perceptive Advisors LLC
1.72M
3.6%
-297.71K
-14.74%
Dec 31, 2025
State Street Investment Management (US)
1.58M
3.31%
+44.64K
+2.90%
Dec 31, 2025
Wellington Management Company, LLP
1.41M
2.94%
-95.68K
-6.37%
Dec 31, 2025
Fred Alger Management, LLC
1.37M
2.87%
+55.32K
+4.20%
Dec 31, 2025
Juniper Investment Company, LLC
1.19M
2.48%
-144.56K
-10.84%
Dec 31, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
AAM Sawgrass US Small Cap Quality Growth ETF
4.14%
Unusual Whales Subversive Democratic Trading ETF
3.4%
ROBO Global Healthcare Technology & Innovation ETF
1.85%
State Street SPDR S&P Health Care Equipment ETF
1.74%
Invesco S&P SmallCap Health Care ETF
1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
0.69%
First Trust Small Cap Growth AlphaDEX Fund
0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
0.42%
iShares Micro-Cap ETF
0.33%
더 보기
AAM Sawgrass US Small Cap Quality Growth ETF
비율4.14%
Unusual Whales Subversive Democratic Trading ETF
비율3.4%
ROBO Global Healthcare Technology & Innovation ETF
비율1.85%
State Street SPDR S&P Health Care Equipment ETF
비율1.74%
Invesco S&P SmallCap Health Care ETF
비율1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
비율0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
비율0.69%
First Trust Small Cap Growth AlphaDEX Fund
비율0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
비율0.42%
iShares Micro-Cap ETF
비율0.33%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI